DD French regulation Flashcards
What are the 3 bigs things the FDA regulates when it comes to drugs?
1.) Categorization 2.) Evaluation for Safety and Efficacy 3.) Equivalence for generic vs brand name drugs
What are the 4 FDA categories of drugs.
1.) Prescription drugs 2.) Controlled Substances 3.) OTC drugs 4.) Dietary supplements
What is the main thing state governments control when it comes to drugs?
Who may prescribe
Which government agency controls the prescription of controlled substances?
DEA
What is the main thing local governments control when it comes to drugs?
Laws regarding drug use within their jurisdiction. (ex. no pot shops near schools)
Define ?drug.?
A drug is a therapeutic agent intended to treat, cure, prevent, or diagnose a disease.
T or F: Dietary supplements must be tested for safety and efficacy before they can be sold.
FALSE
List the phases of drug development and approval.
Animal testing (pre-clinical trials), Phase I, Phase II, Phase III, Phase IV (postmarketing)
T or F: Animal trials involve testing for safety, efficacy, and effect on reproduction.
TRUE. Also look at selectivity and mechanism
How many patients/volunteers usually participate in Phase I trials?
20-100
T or F: Phase I trials look at drug safety.
TRUE
T or F: Phase I trials look at drug pharmacokinetics.
TRUE
T or F: Phase II clinical trials involve volunteers who do not have the disease the drug is intended to treat.
FALSE. Phase II clinical trials test the drug on real patients with the disease the drug is intended to treat.
What is used to compare the a new drug to in Phase II clinical trials?
Placebo - single blind or open label
What is used to compare the a new drug to in Phase III clinical trials?
Placebo or current standard of treatment - double blind and cross-over techniques
T or F: If a drug is going to fail, it is mostly likely to fail out of Phase II clinical trials.
TRUE
If a new drug for a life-threatening condition appears promising in Phase III trials, what can its developers get to move it to market faster?
Accelerated-development review
T or F: It is possible for a generic drug to get FDA approval after demonstrating bioequivalency only.
TRUE. This is called getting an Abbreviated New Drug Application (ANDA). Otherwise they would have to show pharmaceutical equivalence as well.
T or F: The FDA can regulate how a drug is actually used by doctors.
FALSE
T or F: Once a drug reaches Phase IV (post-marketing), it no longer needs to be monitored for safety.
FALSE
T or F: Generic drugs are inferior to brand name drugs.
FALSE
When is it advisable to avoid switching between a generic and a brand name drug?
Narrow therapeutic window, poor bioavailability, non-linear pharmacokinetics. The slight differences in batches can make a difference in some cases.
How is bioequivalency measured for generic versus brand name drugs?
They must have the same extent of absorption (AUC) and rate of absorption (Cp max - same peak drug concentration)
What are the set limits for AUC and Cp max for a generic drug? (was in absorption lectures as well)
Ratio of Generic/Brand mean and 90% confidence interval of AUC and Cp max must be within 80-125%
T or F: Nonprescription drugs are evaluated the exact same way as prescription drugs.
TRUE